Abstract
Glioblastoma is the most frequent brain tumor in adults and is the most lethal form of human cancer. Despite the improvements in treatments, survival of patients remains poor. In order to identify microRNAs (miRs) involved in glioma tumorigenesis, we evaluated, by a miRarray, differential expression of miRs in the tumorigenic glioma LN-18, LN-229 and U87MG cells compared with the non-tumorigenic T98G cells. Among different miRs we focused our attention on miR-221 and -222. We demonstrated the presence of a binding site for these two miRs in the 3′ untranslated region of the protein tyrosine phosphatase μ (PTPμ). Previous studies indicated that PTPμ suppresses cell migration and is downregulated in glioblastoma. Significantly, we found that miR-221 and -222 overexpression induced a downregulation of PTPμ as analyzed by both western blot and real-time PCR. Furthermore, miR-222 and -221 induced an increase in cell migration and growth in soft agar in glioma cells. Interestingly, the re-expression of PTPμ gene was able to revert the miR-222 and -221 effects on cell migration. Furthermore, we found an inverse correlation between miR-221 and -222 and PTPμ in human glioma cancer samples. In conclusion, our results suggest that miR-221 and -222 regulate glioma tumorigenesis at least in part through the control of PTPμ protein expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Brady-Kalnay SM, Rimm DL, Tonks NK . (1995). Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo. J Cell Biol 130: 977–986.
Burgoyne AM, Palomo JM, Phillips-Mason PJ, Burden-Gulley SM, Major DL, Zaremba A et al. (2009a). PTPmu suppresses glioma cell migration and dispersal. Neuro Oncol 11: 767–778.
Burgoyne AM, Phillips-Mason PJ, Burden-Gulley SM, Robinson S, Sloan AE, Miller RH et al. (2009b). Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration. Cancer Res 69: 6960–6968.
Calin GA, Croce CM . (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857–866.
Cerchia L, Esposito CL, Jacobs AH, Tavitian B, de Franciscis V . (2009). Differential SELEX in human glioma cell lines. PLoS ONE 4: e7971.
Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G et al. (2005). Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351–1358.
Conti A, Aguennouz M, La Torre D, Tomasello C, Cardali S, Angileri FF et al. (2009). miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol 93: 325–332.
Croce CM . (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704–714.
Demuth T, Berens ME . (2004). Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70: 217–228.
Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS et al. (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28: 5369–5380.
Garofalo M, Condorelli GL, Croce CM, Condorelli G . (2010). MicroRNAs as regulators of death receptors signaling. Cell Death Differ 2010: 2.
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A et al. (2009). miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16: 498–509.
Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C et al. (2008). MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27: 3845–3855.
Giese A, Bjerkvig R, Berens ME, Westphal M . (2003). Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624–1636.
Huse JT, Holland EC . (2010). Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10: 319–331.
Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, Zanca C et al. (2010). miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res 70: 3638–3646.
Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M et al. (2008). microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566–3572.
Liang Y, Li X-Y, Rebar EJ, Li P, Zhou Y, Chen B et al. (2002). Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell type-specific DNase I accessibility. J Biol Chem vol277: pp. 20087–20094.
Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M et al. (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101: 9740–9744.
Livak KJ, Schmittgen TD . (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.
Nuovo G, Lee EJ, Lawler S, Godlewski J, Schmittgen T . (2009). In situ detection of mature microRNAs by labeled extension on ultramer templates. Biotechniques 46: 115–126.
Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G et al. (2006). MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13: 497–508.
Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B et al. (2010). miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 107: 264–269.
Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP . (2010). A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465: 1033–1038.
Purow B, Schiff D . (2009). Advances in the genetics of glioblastoma: are we reaching critical mass? Nat Rev Neurol 5: 419–426.
Ridder LI, Laerum OD, Mørk SJ, Bigner DD . (1987). Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice. Acta Neuropathologica 72: 207–213.
Sredni ST, Bonaldo Mde F, Costa FF, Huang CC, Hamm CA, Rajaram V et al. (2010). Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst 26: 279–283.
Tran B, Rosenthal MA . (2010). Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci 17: 417–421.
Xia H, Qi Y, Ng SS, Chen X, Li D, Chen S et al. (2009). microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res 1269: 158–165.
Acknowledgements
This work was partially supported by funds from Associazione Italiana Ricerca sul Cancro, AIRC to GC (Grant n.ro 10620) and MERIT (RBNE08E8CZ_002) to GC. CQ is supported by a Federazione Italiana Ricerca sul Cancro (FIRC) Post-Doctoral Research Fellowship. CZ is supported by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Quintavalle, C., Garofalo, M., Zanca, C. et al. miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. Oncogene 31, 858–868 (2012). https://doi.org/10.1038/onc.2011.280
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.280
Keywords
This article is cited by
-
Preliminary study on miRNA in prostate cancer
World Journal of Surgical Oncology (2023)
-
The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells
Journal of NeuroVirology (2022)
-
Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastoma
Scientific Reports (2020)
-
DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells
Oncogenesis (2020)
-
Obesity impacts the regulation of miR-10b and its targets in primary breast tumors
BMC Cancer (2019)